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Abstract
Background—Bone marrow stromal cell (BMSC) paracrine factor(s) can induce apoptosis in
bone metastatic prostate cancer (PCa) cell lines. However, the PCa cells that escape BMSC-
induced apoptosis can upregulate cytoprotective autophagy.
Methods—C4-2, C4-2B, MDA PCa 2a, MDA PCa 2b, VCaP, PC3, or DU145 PCa cell lines
were grown in BMSC conditioned medium and analyzed for mRNA and/or protein accumulation
of p62 (also known as Sequestome-1/SQSTM1), Microtubule-associated Protein 1 Light Chain 3B
(LC3B), or Lysosomal-associated Membrane Protein 1 (LAMP1) using quantitative polymerase
chain reaction (QPCR), western blot, or immunofluorescence. Small interfering RNA (siRNA)
was used to determine if p62 is necessary PCa cell survival.
Results—BMSC paracrine signaling upregulated p62 mRNA and protein in a subset of the PCa
cell lines. The PCa cell lines that were insensitive to BMSC-induced apoptosis and autophagy
induction had elevated basal p62 mRNA and protein. In the BMSC-insensitive PCa cell lines,
siRNA knockdown of p62 was cytotoxic and immunostaining showed peri-nuclear clustering of
autolysosomes. However, in the BMSC-sensitive PCa cell lines, p62 siRNA knockdown was not
appreciably cytotoxic and did not affect autolysosome subcellular localization.
Conclusions—A pattern emerges wherein the BMSC-sensitive PCa cell lines are known to be
osteoblastic and express the androgen receptor, while the BMSC-insensitive PCa cell lines are
characteristically osteolytic and do not express the androgen receptor. Furthermore, BMSC-
insensitive PCa may have evolved a dependency on p62 for cell survival that could be exploited to
target and kill these apoptosis-resistant PCa cells in the bone.
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Introduction
To maintain homeostasis, cells can utilize autophagy to clear, degrade, and recycle
cytoplasmic biomolecules (1,2). During autophagy, cytoplasmic contents are enveloped into
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a double membrane vesicle called the autophagosome. The autophagosome fuses with the
lysosome, forming the autolysosome, wherein hydrolases degrade the vesicle cargo. The
degraded products are transported back into the cytoplasm for reuse by the cell (1,2).
Microtubule-associated Protein 1 Light Chain 3 (LC3) is an autophagosome membrane
protein that commonly serves as an autophagy induction and flux marker (3). When
autophagy is induced, free cytoplasmic LC3 (LC3-I) is conjugated to
phosphatidylethanolamine to form membrane-bound LC3 (LC3-II) (4). LC3-II is located on
the outer and inner autophagosome double membrane (5). During autophagic flux, outer
LC3-II is proteolytically cleaved from the membrane to replenish free LC3 and inner
membrane LC3-II is degraded in the autolysosome (3,6,7).
The selective engulfment of cytoplasmic contents into autophagosomes requires auxiliary
proteins, such as p62 (also known as Sequestome-1/SQSTM1) (2,8), a multifunctional,
multi-domain scaffolding protein that serves as a hub for several signaling pathways,
including autophagy-mediated protein degradation, Nuclear Factor Kappa-B (NF-κB)
activation, and Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) activation (8,9). In
autophagy, p62 sequesters K63-linked polyubiquitinated proteins into the autophagosome
through its ubiquitin-association (UBA) and LC3-interacting (LIR) domains (8,10-12). As a
consequence, p62 also is degraded in the autolysosome (10,11). In transgenic mice or human
specimens, p62 overaccumulation is associated with degenerative diseases, including
neurodegeneration (13), liver cirrhosis (14-16), and cardiac myopathy (17). p62
overaccumulation can also promote tumor cell survival. Although the mechanisms of p62
function in the different pathologies remain unclear, possible mechanisms of p62-mediated
tumorigenesis involve genetic instability, NF-κB-mediated inflammatory response, or
NRF2-mediated antioxidant signaling. For example, p62 overexpression in autophagy-
deficient cells leads to genetic instability and increases tumorigenesis in mouse allografts
(18). In addition, in K-ras driven lung (19) and pancreatic (20) tumors, p62 is elevated and
contributes to constitutive NF-κB activation by binding to and activating TNF receptor-
associated factor 6 (TRAF6). Furthermore, in liver cancer, overaccumulated p62 binds to
Kelch-Like ECH-Associated Protein (KEAP1), disrupting KEAP1-NFR2 interaction and
allowing NRF2 transactivation of antioxidant and detoxifying genes (21). Notably,
knockdown of p62 in mice reduces tumor growth (19,22). Indeed, p62 was found to be
elevated in prostate (23), breast (24-26), pancreatic (20), lung (19,27), and liver (21)
cancers.
Over 80% of PCa mortality is attributed to bone metastasis (28) and, thus, it is crucial to
understand the molecular mechanisms that enable PCa survival in the bone. Through this
study, we uncovered the effect of bone marrow stromal cell (BMSC) paracrine factors on
p62 mRNA expression and protein accumulation in bone metastatic PCa cells. Furthermore,
we discovered that subtypes of PCa cell lines show differential autophagy induction, p62
accumulation, and p62-mediated cell survival in response to BMSC paracrine signaling. We
conclude that paracrine factors in the bone microenvironment contribute to PCa cell survival
and adaptation in the bone through a mechanism involving p62 regulation and propose that
p62 may be a valuable biomarker and rational target for apoptosis-resistant bone metastatic
PCa cells.
Materials and Methods
Cell Culture
PCa cell lines (C4-2, C4-2B, DU145, MDA PCa 2a, MDA PCa 2b, PC3, VCaP) and bone
marrow stromal cell lines (HS-5, HS-27a) were grown in a 37°C, 5.0% (v/v) CO2 growth
chamber. C4-2, C4-2B, DU145, and PC3 cell lines were cultured in T-medium (Gibco/
Invitrogen) supplemented with 5% (v/v) fetal bovine serum (FBS) (Atlanta Biologicals), 0.4
Chang et al. Page 2
Prostate. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
mM L-glutamine (L-glut) (Gibco/Invitrogen), and 10 U/ml penicillin G sodium and 10 mg/
ml streptomycin sulfate (pen-strep) (Gibco/Invitrogen). MDA PCa 2a and MDA PCa 2b
were cultured in BRFF-HPC1 medium (AthenaES; 0403) supplemented with 20% (v/v)
FBS, 0.4 mM L-glut, and pen-strep. VCaP, HS-5, and HS-27a cell lines were cultured in low
glucose DMEM medium (Gibco/Invitrogen) supplemented with 10% FBS, 0.4 mM L-glut,
and pen-strep.
Conditioned Medium Treatment
To obtain bone marrow stromal cell conditioned medium, culture medium was removed
from HS-5 or HS-27a cultured cells and replaced with fresh T-medium supplemented with
5% FBS, L-glut, pen-strep. After 3 days incubation, the conditioned T-medium was
collected and spun at 1400 rpm for 3 minutes to remove cell debris. The conditioned media
were stored at -80°C. T-medium supplemented with 5% FBS, L-glut, pen-strep served as the
control growth medium.
Drug and siRNA Treatments
Cells were treated with chloroquine diphosphate aqueous solution (Invitrogen; P36235).
Cells were transfected with a pool of three unique 27-mer p62/SQSTM1 siRNA duplexes
(Origene; SR305865) using siTran 1.0 transfection reagent (Origene; TT300001). Western
blot analysis and/or immunostaining were used to confirm loss of p62 protein.
Western Blot Analysis and Antibodies
Protein was isolated from cells using NP40 lysis buffer (0.5% NP-40 (Sigma; NP40S), 50
mM Tris (pH 7.5), 150 mM NaCl, 3 mM MgCl2, 1× protease inhibitors (Roche;
0505489001). Protein concentration was measured using the Pierce BCA Protein Assay Kit
(Thermo Scientific; 23225). For western blot analysis, equal protein concentrations were
loaded onto and separated in 17% (w/v) sodium dodecyl sulfate polyacrylamide gel (40%
acrylamide/bis-acrylamide solution; Bio-Rad; 161-0148). Proteins were transferred from the
gel to 0.45 μm pore size nitrocellulose membrane (Bio-Rad; 162-0094) and total protein
visualized using Ponceau S (Sigma; P7170). The membrane was blocked with 3% (w/v)
bovine serum albumin (BSA) (Sigma-Aldrich; A7906) in 1× TBST (20 mM Tris, pH 7.6,
150 mM NaCl, 0.05% Tween-20). Primary and secondary antibodies were diluted in 3%
BSA/1× TBST. Protein blot bands were visualized using Pierce ECL Western Blotting
Substrate (Thermo Scientific; 32106) and imaged using the Fujifilm LAS-4000 imager
(Fuji). Densitometry: Densitometry of western blot bands was performed using Image J
software (http://rsbweb.nih.gov/ij/). To determine relative protein levels across treatments
and/or cell lines, densitometric values for LC3B or p62 were first normalized to β-actin or
Ponceau S stain loading controls and then normalized to a control treatment (set at 1.0).
When comparing across cell lines, total protein (i.e. Ponceau S stain) was used as the
loading control. Primary antibodies: LC3B (Novus Biologicals; NB600-1384), p62/
SQSTM1 (Abnova; H00008878-M01), β-actin (Abcam; ab8226). Secondary antibodies:
sheep anti-mouse (Jackson ImmunoResearch Laboratories; 515-035-062), goat anti-rabbit
(Sigma-Aldrich; A6154).
RNA Extraction and Quantitative Polymerase Chain Reaction (QPCR)
To examine mRNA expression, cells were washed twice with 1× PBS and total RNA was
extracted from the cells using Trizol reagent according to the manufacturer's instructions
(Invitrogen; 15596-026) RNA was DNAse-treated (Ambion; AM1906) for 30 minutes at
37°C and, following, cDNA was made using Quanta Biosciences qScript cDNA Super mix
(VWR; 95048). The QPCR reaction was prepared using Quanta Bioscience SYBR Green
Super mix (VWR; 95030-214). Primers specific for p62 were used and data was normalized
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to the β-actin transcript levels. Relative mRNA levels were calculated using the 2-ΔΔCT
method. p62 primers: Forward: AAA TGG GTC CAC CAG GAA ACT GGA; Reverse:
TCA ACT TCA ATG CCC AGA GGG CTA. β-actin primers: Forward: GAT GAG ATT
GGC ATG GCT TT; Reverse: CAC CTT CAC CGG TCC AGT TT.
Cell Viability
Calcein AM and ethidium homodimer 1 (EthD-1) fluorescent probes were used to stain live
and dead cells, respectively, according to manufacturer's instructions (Molecular Probes;
L3224). Briefly, 2 μM calcein AM and 4 μM EthD-1 were added directly to cells in culture.
Following incubation, the cells were trypsinized and transferred to a 96-well tissue culture
plate. Cell fluorescence was measured using the Infinite® M200 microplate reader (Tecan).
Fluorescent cells also were imaged in the 96-well plate at 4× magnification (sufficient to
capture 10,000 cells in a microscopy field) and counted by using Image J software (http://
rsbweb.nih.gov/ij/). Cell viability was determined using the calculation live cells/(live +
dead cells).
Immunofluorescence
Cells were fixed and permeabilized with 100% methanol at -20°C for at least 30 minutes.
Cells were blocked with 2.5% BSA in 1× phosphate buffered saline (PBS) at room
temperature for at least 30 minutes. Antibodies were diluted in 2.5% BSA in 1× PBS. Cells
were incubated in primary antibody at 4°C overnight, washed with 1× PBS, and then
incubated in fluorescently labeled secondary antibody at 4°C in the dark, overnight. Primary
antibodies: LC3B (Novus Biologicals; NB600-1384), p62/SQSTM1 (Abnova; H00008878-
M01), LAMP1 (University of Iowa Developmental Studies Hybridoma Bank; H4A3).
Fluorescently labeled secondary antibodies: Alexafluor 488, goat anti-mouse (Invitrogen;
A11001), Alexafluor 568, goat anti-rabbit (Invitrogen; A11061).
Microscopy
Images were taken and processed using the Eclipse TE300 inverted microscope (Nikon) and
NIS Elements software (Nikon) (40× magnification, scale bar = 100 μm). Alexafluor 488
and 568 fluorescence was detected using the FITC and Texas Red filters, respectively.
Statistics
Statistical significance was determined using unpaired student t test.
Results
HS-5 paracrine factor(s) can induce PCa autophagy
We previously reported that the hematopoietic HS-5 bone marrow stromal cell line, but not
the HS-27a structural bone marrow stromal cell line, secretes a milieu of soluble factor(s)
that induce LC3B-II protein accumulation in C4-2 and C4-2B bone metastatic PCa cell lines
(29). We expanded our analysis to determine if LC3B-II upregulation is a common response
of bone metastatic PCa cell lines (Table I, (30-42)) to HS-5 secreted factor(s). Thus, we
grew MDA PCa 2a, MDA PCa 2b and VCaP PCa cell lines for several days in control
growth medium or in HS-5 or HS-27a bone marrow stromal cell (BMSC) conditioned
medium and used western blot analysis to determine LC3B-II protein levels. As previously
observed for the C4-2 and C4-2B cell lines (29), HS-5 conditioned medium induced greater
LC3B-II accumulation in MDA PCa 2a, MDA PCa 2b and VCaP cells than did control
growth medium or HS-27a BMSC conditioned medium (Fig. 1A).
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LC3B-II accumulation can indicate autophagy induction or, alternatively, inhibition of
autophagic flux (3). Using the lysomotropic inhibitor, chloroquine, we previously showed
that autophagic flux is maintained in C4-2 and C4-2B cells in the presence of HS-5
conditioned medium (29). To further confirm that autophagic flux remains functional in PCa
cells grown in HS-5 conditioned medium, we also treated MDA PCa 2a and MDA PCa 2b
cell lines with 40 μM chloroquine in the presence of HS-5 BMSC conditioned medium for
two days. As observed for C4-2 and C4-2B cell lines (Fig. 1B, (29)), chloroquine increased
LC3B-II accumulation over the vehicle control in MDA PCa 2a and MDA PCa 2b cells
(Fig. 1B). Thus, HS-5 BMSC paracrine factor(s) do not inhibit autophagic flux in the bone
metastatic PCa cell lines analyzed, but rather, induce PCa cell autophagy.
HS-5 paracrine factor(s) can upregulate PCa p62 mRNA and protein
While characterizing HS-5-induced autophagy response in C4-2, C4-2B, MDA PCa 2a,
MDA PCa 2b, and VCaP cell lines, we discovered a steady-state increase in p62 protein that
occurred within one day of growth in HS-5 BMSC conditioned medium (Fig. 1A). For
example, HS5 conditioned medium induced a 1.7- to 4.2-fold increase in p62 protein over
control medium (Fig. 1A). Because p62 sequesters ubiquitinated proteins into the
autophagosome for degradation, it also is degraded through autophagy (10,11). Therefore,
our results were unexpected given that HS-5 conditioned medium induces autophagy and
does not block autophagy flux in PCa cells (Fig. 1, (29)). Furthermore, chloroquine
increased p62 protein in the PCa cell lines grown in control medium or HS-5 or HS-27a
BMSC conditioned medium (Fig. 1B), indicating that p62 is properly degraded through
autophagy under these growth conditions. Therefore we investigated the effect of HS-5
conditioned medium on p62 mRNA levels in the PCa cell lines. Quantitative polymerase
chain reaction (QPCR) revealed that within one day, HS-5 conditioned medium upregulated
p62 mRNA levels (Fig. 1C). Thus, our results suggest (post)transcriptional regulation of
PCa p62 by HS-5-secreted factor(s) and likely do not indicate a defect in autophagic flux.
DU145 and PC3 cell lines show no significant autophagy or p62 induction when exposed
to HS-5 paracrine factor(s)
HS-5 BMSC conditioned medium induces apoptosis in C4-2, C4-2B, and VCaP cells (data
not shown, (43)). Autophagy, which we propose is cytoprotective in this context, is induced
in the surviving subpopulation ((29), data not shown). The DU145 and PC3 bone metastatic
PCa cell lines are less sensitive to HS-5-induced apoptosis (43). Therefore, we predicted that
DU145 and PC3 cells can escape HS-5-induced apoptosis by upregulating cytoprotective
autophagy more efficiently than the apoptosis-sensitive PCa cell lines. To test our
hypothesis, we compared the HS-5-mediated autophagy response of the DU145 and PC3
cells with that of the C4-2 cell line. C4-2, DU145, and PC3 cells were grown in control or
BMSC conditioned medium for two days and analyzed for LC3B protein accumulation.
Relative to control growth medium or HS-27a BMSC conditioned medium, HS-5 BMSC
conditioned medium led to a greater induction of LC3B-I and/or LC3B-II accumulation in
C4-2 cells than in DU145 or PC3 cells (Fig. 2A). For example, relative to control growth
medium, HS-5 conditioned medium increased LC3B-I and LC3B-II levels 4.1- and 5-fold,
respectively, in C4-2 cells, but had comparatively less effect on LC3B-I or LC3B-II protein
levels in PC3 cells (Fig. 2A). Furthermore, while DU145 cells showed an increase in LC3-I
when grown in HS-5 conditioned medium over control growth medium, we could not detect
LC3B-II by western blot (Fig. 2A). Thus, HS-5 paracrine factor(s) have a more profound
effect on autophagy induction in C4-2 cells than in DU145 or PC3 cells.
Because we found that DU145 cells do not accumulate LC3B-II when grown in control
growth medium or BMSC conditioned medium (Fig. 2A), we concluded that canonical
autophagy is not the common mechanism that mediates survival of DU145 and PC3 cells
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exposed to HS-5 paracrine factor(s). However, p62 also promotes cell survival both
dependently and independently of autophagy (9) and is induced by HS-5 conditioned
medium in multiple PCa cell lines (Fig. 1A). Therefore, we compared the effect of HS-5
BMSC conditioned medium on p62 mRNA and protein accumulation in C4-2, DU145 and
PC3 cell lines. Relative to control growth medium, after two days growth in HS-5
conditioned medium, C4-2 cells showed a 3.9- and 2.5-fold increase in p62 mRNA and
protein, respectively (Fig. 2A & B). However, DU145 and PC3 cells showed no
considerable increase in p62 mRNA or protein accumulation when grown in HS-5
conditioned medium (Fig. 2A & B). Taken together, our data reveal that, unlike the C4-2,
C4-2B, MDA PCa 2a, MDA PCa 2b, or VCaP cell lines, the DU145 and PC3 cell lines show
no notable autophagy or p62 induction in response to HS5-secreted paracrine factor(s).
DU145 and PC3 cell lines have high basal p62 levels
While we did not detect a considerable effect of HS-5 conditioned medium on autophagy
induction or p62 mRNA and protein accumulation in DU145 or PC3 cell lines (Fig. 2A &
B), we did observe that DU145 and PC3 cells have comparatively higher basal p62 mRNA
and/or protein levels than the C4-2, C4-2B, MDA PCa 2a, MDA PCa 2b, or VCaP cell lines
(Fig. 2A, B, & C). For example, when normalized to C4-2 basal p62 mRNA (Fig. 2B) or
protein (Fig. 2A), p62 mRNA or protein levels were 11- or 5.5-fold and 2.8- or 3.4-fold
greater in DU145 and PC3 cells, respectively.
Down regulation of p62 is cytotoxic for DU145 and PC3 cell lines
Given that both DU145 and PC3 cell lines have reduced sensitivity to HS-5-induced
apoptosis (43) and show comparatively high basal p62 mRNA and protein levels (Fig. 2),
we explored the possible role of p62 in DU145 and PC3 cell survival. C4-2, DU145 and
PC3 cells were grown in control growth medium and transiently transfected with 40 nM p62
siRNA to reduce p62 protein accumulation (Fig. 3A). Three days following treatment, cells
were analyzed for the presence of live and dead cells by measuring calcein AM and
ethidium homodimer 1 (EthD-1) fluorescence, respectively (graph not shown). Relative to
control siRNA, down regulation of p62 significantly reduced the calcein AM fluorescence
(p-value = 0.003) and increased EthD-1 fluorescence (p-value = 0.014) in PC3 cells. Thus,
p62 mediates PC3 cell survival. However, p62 siRNA did not significantly affect calcein
AM (p-value = 0.29) or EthD-1 (p-value = 0.31) fluorescence in C4-2 cells, implying that
p62 is not necessary for C4-2 cell survival in normal under control growth conditions.
In our experiments, 40 nM p62 siRNA was relatively less effective at reducing p62 protein
accumulation in DU145 cells (Fig. 3A) and did not have an effect on DU145 cell survival
(calcein AM, p-value = 0.49; EthD-1, p-value = 0.17; graph not shown). However, transient
transfection of 60 nM p62 siRNA was sufficient to reduce p62 protein accumulation to
nearly undetectable levels in DU145 cells (Fig. 3A). Therefore, we transfected C4-2, C4-2B,
MDA PCa 2A, MDA PCa 2B, DU145, and PC3 cells grown in control growth medium with
60 nM p62 siRNA and after two days we measured cell viability by counting calcein AM
and EthD-1 fluorescent cells. In control growth media, down regulation of p62 protein
significantly reduced the cell viability of DU145 (p-value ≤ 0.0005) and PC3 (p-value ≤
0.0005) cells, but had less effect on C4-2 (p-value ≤ 0.05), C4-2B, MDA PCa 2a, or MDA
PCa 2b cell viability (Fig. 3B, Supplemental Fig. 1).
When p62 protein was reduced under control growth conditions, C4-2, C4-2B, MDA PCa
2a, and MDA PCa 2b cells did not show as significant of a reduction in cell viability as the
DU145 or PC3 cells (Fig. 3B, Supplemental Fig. 1). However, given that HS-5 BMSC
conditioned medium upregulated p62 mRNA and protein in C4-2, C4-2B, MDA PCa 2a,
and MDA PCa 2b cells (Fig. 1 & 2), we reasoned that p62 may have a cytoprotective
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function in the presence of HS5 conditioned medium. Surprisingly, siRNA-mediated
knockdown of p62 did not reduce the cell viability of C4-2 or C4-2B cells grown in HS-5
conditioned medium (Fig. 3B). However, transient transfection of 60 nM p62 siRNA into
DU145 and PC3 cells grown in HS-5 conditioned medium for two days significantly
reduced the cell viability (DU145, p-value ≤ 0.0005 ; PC3, p-value ≤ 0.005) (Fig. 3B).
Interestingly, we were unable to appreciably reduce p62 protein levels using siRNA in MDA
PCa 2a or MDA PCa 2b cells grown in HS-5 conditioned medium (Supplemental Fig. 1).
Taken together, these data demonstrate that that loss of p62 protein is more significantly
cytotoxic for DU145 and PC3 cells than for C4-2, C4-2B, MDA PCa 2a, or MDA PCa 2b
cell lines grown in control or HS-5 BMSC conditioned growth media.
Down regulation of p62 alters autolysosomal subcellular localization in DU145 and PC3
cell lines
To investigate the effect of the loss of p62 protein on autolysosome accumulation in
individual cells, we performed co-immunostaining for LC3B and p62 or the lysosomal
membrane protein, LAMP1, in C4-2, C4-2B, DU145, and PC3 cells transiently transfected
with 60 nM p62 siRNA and grown in control growth medium or HS-5 BMSC conditioned
medium for two days. In C4-2 and C4-2B cells grown in control growth medium or HS-5
conditioned medium, discrete co-localized LC3B and LAMP1 structures (autolysosomes)
were found distributed throughout the cytoplasm and around the nucleus in cells transfected
with control siRNA or p62 siRNA (Fig. 4A & B). However, in PC3 cells, the subcellular co-
localization of LC3B and LAMP1 changed from cytoplasmic distribution to peri-nuclear
clustering when p62 was down regulated (Fig. 4A & B, arrows). LC3B puncta did not
accumulate in DU145 cells (data not shown), presumably because DU145 cells do not
accumulate LC3B-II (Fig. 2A). However, as observed for PC3 cells, p62 siRNA led to peri-
nuclear clustering of LAMP1 in DU145 cells grown in control growth medium or HS-5
conditioned medium (Fig. 4A & B, arrows). Thus, the loss of p62 has a similar effect on
lysosome and autolysosome subcellular localization in DU145 and PC3 cell lines in grown
in either control growth medium or HS-5 BMSC conditioned medium, but p62 siRNA does
not affect autolysosome subcellular localization in C4-2 or C4-2B cells.
Discussion
Sensitivity to HS-5 secreted factors correlates with PCa androgen receptor expression and
bone-forming tumor type
An intriguing similarity emerges for the PCa cell lines which we discovered can respond to
HS-5 BMSC-induced apoptosis, autophagy, or p62 accumulation in contrast to the PCa cell
lines that did not show a significant apoptosis, autophagy, or p62 induction response to HS-5
paracrine factor(s) (Fig. 5). The PCa cell lines (C4-2, C4-2B, MDA PCa 2a, MDA PCa 2b,
and VCaP) that were sensitive to HS-5 conditioned medium express the androgen receptor
(41) and form primarily osteoblastic lesions in mice (33,42,44), while the HS-5-insensitive
PCa cells lines (DU145 and PC3) do not express the androgen receptor (41) and form
primarily osteolytic lesions (37). It is feasible that the osteolytic PCa cell types either secrete
factor(s) that neutralize the bone cell paracrine signals that induce apoptosis, autophagy, or
p62 accumulation, or alternatively lack internal pathways that allow them to respond to
these signals. Another possibility is that the androgen receptor can directly or indirectly
mediate the induction of cytoprotective autophagy and p62 upregulation in PCa cells in
response to BMSC-secreted apoptosis-inducing factor(s). Experiments are underway to
determine the mechanistic role of the androgen receptor in HS-5-induced autophagy and p62
upregulation and to determine if key autophagy regulators are transcriptional targets of the
androgen receptor.
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p62 is required for the cell survival of HS-5-insensitive cell lines
If the androgen receptor indeed mediates autophagy induction in response to HS-5 BMSC
paracrine factors, then not surprisingly, DU145 and PC3 PCa cells, which lack androgen
receptor expression, were non-responsive to HS-5-induced autophagy. Interestingly, the PC3
cells accumulated more basal LC3B-II than did the HS-5-sensitive PCa cell lines (Fig. 2 &
3, data not shown), implying that high basal autophagy protects PC3 cells from HS-5-
induced apoptosis. While PC3 cells may have higher basal autophagy, DU145 cells do not
carry out canonical autophagy (45). For example, we did not detect LC3B-II (Fig. 2 & 3) or
LC3B-decorated autophagosomes or autolysosomes (data not shown) in the DU145 cells.
Furthermore, Ouyang and colleagues recently reported that ATG5, which promotes
autophagosome formation, is mutated and non-functional in DU145 cells (45). Yet, both
DU145 and PC3 cell lines are insensitive to HS-5-induced apoptosis (43), suggesting that
these cell lines share an androgen receptor-independent – and possibly autophagy-
independent – survival mechanism. Our data reveals that one such shared alternative cell
survival mechanism requires p62 (Fig. 5). Because p62 is a multifunctional protein, there are
several candidate cell survival pathways that may be compromised in DU145 and PC3 cells
when p62 expression is reduced. For example, in addition to mediating autophagic
degradation of cytotoxic polyubiquitinated protein aggregates, p62 also promotes cell
survival through NF-κB activation and NRF2 antioxidant signaling (8,9). It will be
important to determine the regulation and activity of the various p62-mediated cell survival
pathways when p62 is knocked down in DU145 and PC3 PCa cell lines, as these pathways
may serve as biomarkers or therapeutic targets.
PCa cell lines with high basal p62 may have evolved a cell survival requirement for p62
We initially predicted that the steady-state upregulation of p62 mRNA and protein levels in
HS-5-sensitive PCa cell lines exposed to HS-5 paracrine signaling reflected a cytoprotective
response. However, in our experiments, p62 did not appear necessary for the survival of
HS-5-sensitive PCa cell lines under normal growth conditions or in the presence of HS-5
paracrine factor(s) (Fig. 3, Supplemental Fig. 1, data not shown). Our results imply that
under normal growth conditions or in the presence of HS-5 paracrine factors, the HS-5-
sensitive PCa cell lines, which do not normally accumulate high levels of p62, have cell
survival pathways that can compensate for the loss of p62.
In contrast, under normal growth conditions or in the presence of HS-5 BMSC paracrine
factors DU145 and PC3 cells showed high basal levels of p62 mRNA and protein and
required p62 for cell survival (Fig. 2 & 3). Thus, we propose that the DU145 and PC3 PCa
cell lines have evolved a cell survival dependency on p62 and that constitutive, long-term
p62 elevation may be important for PCa adaptation to the bone microenvironment (Fig. 5).
Defective autophagy flux accounts for, in part, the high basal p62 protein accumulation in
DU145 cells (45). However, we also saw an increase in basal p62 mRNA levels in both the
DU145 and PC3 cells (Fig. 2), suggesting enhanced transcriptional activity and/or mRNA
stability. Furthermore, HS-5-induced p62 accumulation occurred at the level of mRNA in
the HS-5-sensitive PCa cell lines (Fig. 2). Transcription factors and microRNAs shown to
regulate p62 expression or mRNA stability include NF-κB (20), NRF2 (46), Farnesoid
Receptor X (47), Prostate Derived Ets Factor (26), or miR-17/20/93/106 (48)). One or more
of these regulators of p62 mRNA levels may mediate HS-5-induced p62 expression in the
HS-5-sensitive cell lines and these regulators may have altered activity in the DU145 and
PC3 cell lines. Future investigation into the mechanistic regulation of p62 expression in the
PCa cells lines will provide strategies to target p62 function in cancer cells.
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Autolysosome peri-nuclear clustering is associated with enhanced autophagy induction
and flux
In DU145 and PC3 cells we observed that lysosomes and autolysosomes, respectively, are
normally distributed throughout the cytoplasm and around the nucleus (Fig. 4). However,
p62 knockdown caused peri-nuclear clustering of (auto)lysosomes in DU145 and PC3 cells.
Other laboratories have reported that autolysosome clustering is associated with enhanced
autophagy induction and flux in response to viral infection (49) or hypertonic stress (50) . In
accordance, we detected peri-nuclear clustering of (auto)lysosomes in DU145 and PC3 cells
that had avoided p62 siRNA-mediated cell death at the time of analysis and thus the
(auto)lysosome peri-nuclear clustering could have indicated a cell survival response.
Alternatively, p62 siRNA induced (auto)lysosome clustering in DU145 and PC3 cells could
be an indicator of impending cell death, as this altered subcellular localization of
autolysosomes was not detected in C4-2 cells which are comparatively insensitive to p62
siRNA-mediated cell death . The mechanism of the p62-siRNA-induced (auto)lysosome
clustering is unclear, but likely involves regulation of trafficking along microtubules
(49,50).
Conclusion
p62 may be a rational target for bone metastatic PCa
p62 is overexpressed in multiple cancer types, including PCa, and can correlate with disease
progression (19-21,23-27). In line with these findings, our data suggests that the bone
microenvironment can contribute to the upregulation of p62 mRNA and protein in
metastatic PCa cells and it will be important to determine p62 expression in patient bone
metastases. Notably, DU145 and PC3 cell lines represent a PCa cell subtype that would be
resistant to androgen deprivation or anti-androgen therapies due to lack of androgen receptor
expression. Importantly, our data suggest that treatment resistant PCa tumors could be
identified by p62 expression and subsequently killed by targeting p62 expression and/or the
function of p62 in one or more pathways, including autophagy, NF-κB activation, or NRF2
signaling. In line with our reasoning, knockdown of p62 accumulation in bone marrow
stromal cells attenuated, among several signaling cascades, NF-κB signaling and cytokine
secretion and concomitantly attenuated bone marrow stromal cell paracrine support of
multiple myeloma cell proliferation (51). Thus, it is intriguing to speculate that targeting p62
expression and/or function in bone metastatic PCa cells would not only lead to PCa cell
death, but could disrupt potential p62-mediated, tumor-promoting cross talk between PCa
and bone cells in the metastatic microenvironment.
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Figure 1. HS-5 BMSC paracrine factor(s) can induce autophagy and p62 mRNA and protein
accumulation in PCa cell lines
(A) MDA PCa 2a, MDA PCa 2b, and VCaP PCa cell lines were grown in control growth
medium or in conditioned medium (CM) from HS-5 or HS-27a BMSCs for the time points
indicated. LC3B and p62 protein levels were detected using western blot and relative protein
levels calculated as described in materials and methods. HS-5 CM upregulated LC3B-II and
p62 protein in PCa cell lines. (B) C4-2B, MDA PCa 2a and MDA PCa 2b PCa cell lines
were grown in control growth medium or HS-5 or HS-27a CM in the absence or presence of
40 μM chloroquine (CQ) for two days. CQ led to LC3B-II and p62 accumulation in each
growth medium. (C) C4-2, C4-2B, MDA PCa 2a, and MDA PCA 2b PCa cell lines were
grown in control growth medium or HS-5 or HS-27a CM for one day. p62 mRNA levels
were determined using QPCR and relative fold mRNA levels graphed. Error bars represent
standard deviation of two or three biological replicates. P-value, *≤ 0.05, ** ≤0.005. HS-5
conditioned medium upregulated p62 mRNA in the PCa cell lines.
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Figure 2. DU145 and PC3 PCa cell lines are less responsive to HS-5-induced accumulation of
LC3B-II or p62 and have comparatively high basal p62 accumulation
(A) C4-2, DU145, or PC3 cell lines were grown in control growth medium or HS-5 or
HS-27a BMSC conditioned medium (CM) for two days and analyzed by western blot for
LC3B and p62. Relative protein levels were determined as described in materials and
methods. HS-5 CM upregulated LC3B and p62 protein accumulation in C4-2 cells to a
greater extent than in DU145 or PC3 cell lines. However, basal LC3B-II and/or p62 levels
were higher in DU145 or PC3 cells than in C4-2 cells. (B) C4-2, DU145, or PC3 cell lines
were grown in control growth medium or HS-5 or HS-27a CM for two days. p62 mRNA
levels were determined using QPCR and relative fold mRNA levels graphed. Error bars
represent standard deviation of three biological replicates. P-value, *≤ 0.05, ** ≤0.005, ***≤
0.0005. HS-5 CM upregulated p62 mRNA in C4-2 cells, but not in DU145 or PC3 cell lines.
However, PC3 and DU145 cells showed higher basal p62 mRNA than C4-2 cells. (C) PCa
cell lines were grown in control growth medium for two days. DU145 and PC3 cell lines had
comparatively high p62 protein levels.
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Figure 3. Down regulation of p62 mRNA is cytotoxic for DU145 and PC3 PCa cell lines
(A) (Left) C4-2, PC3, or DU145 cells were grown in control growth medium in the presence
of 40 nM non-target control siRNA or 40 nM p62 siRNA for three days. LC3B and p62
protein levels were detected using western blot and relative protein levels determined as
describe in materials and methods. Two biological replicates are shown for each treatment.
Transfection of 40 nM p62 siRNA was sufficient to reduce p62 protein accumulation to
almost undetectable levels in C4-2 and PC3 cells lines, but not in DU145 cells. (Right)
DU145 cells grown in control growth medium or HS-5 conditioned medium (CM) were
transiently transfected with 60 nM non-target control siRNA or 60 nMp62 siRNA for two
and three days. Transfection of 60 nM p62 siRNA was sufficient to reduced p62 protein to
almost undetectable levels in DU145 cells. (B) C4-2, C4-2B, PC3 and DU145 cells grown in
PCa control growth medium or HS-5 CM were transfected with 60 nM non-target control
siRNA or 60 nM p62 siRNA for two days. Live and dead cells were stained with calcein
AM and ethidium homodimer 1 (EthD-1) fluorescent dyes, respectively, and live and dead
cells were counted to determine cell viability. The error bars represent standard deviation of
three biological replicates. P-value, * < 0.05, ** < 0.005, *** <0.0005. p62 siRNA reduced
cell viability more significantly in DU145 and PC3 cells than in C4-2 or C4-2B cells.
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Figure 4. Loss of p62 alters autolysosome subcellular localization
C4-2, C4-2B, PC3, and DU145 PCa cells were grown in (A) control growth medium or (B)
HS-5 conditioned medium (CM) and treated with 60 nM non-target control siRNA or 60 nM
p62 siRNA. After two days, cells were fixed and co-immunostained for p62 (FITC) and
LC3B (Texas Red) or LC3B (Texas Red) and LAMP1 (FITC). Immunofluorescent cells
were imaged at 40× magnification, scale bar = 100 μm. Shown are matched images of cells
co-immunostained for p62 and LC3B and a merged image of cells co-immunostained for
LC3B and LAMP1. p62 siRNA led to loss of total p62 protein in C42, C4-2B, and PC3 cells
and loss of p62 puncta in DU145 cells. p62 siRNA caused peri-nuclear clustering of
autolysosome and lysosomes, respectively, in PC3 and DU145 cells (arrow, representative
cell). However, in C4-2 or C4-2B cells, p62 siRNA did not alter subcellular localization of
LC3B or LAMP1 when p62 protein levels were reduced (arrow, representative cell).
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Figure 5. Proposed Model
Based on our data we propose the following model. (1) Prostate cancer (PCa) cells that are
androgen receptor positive (AR+) and form largely osteoblastic (OB) lesions represent a
PCa subtype that is sensitive to bone marrow stromal cell (BMSC) paracrine induction of
PCa apoptosis and induction of autophagy and p62 accumulation in the surviving cell
population. PCa cells that are androgen receptor negative (AR-) and form largely osteolytic
(OL) lesions represent a PCa cell subtype that has high basal p62 levels and is insensitive to
BMSC paracrine-induced PCa apoptosis, autophagy, or p62 upregulation. (2) Loss of p62
(flat arrowhead) is significantly cytotoxic (thick, solid arrow) for BMSC-insensitive PCa
cells, indicating that these cells require p62 for survival. Likewise, BMSC-sensitive PCa
cells that would escape BMSC-induced apoptosis and colonize the bone would evolve (thin,
dashed arrow) into p62-dependent cells due to long-term paracrine induction of p62
accumulation.
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Table 1
Cell Line List
Listed are the prostate cancer (above darker line) and bone marrow stromal (below darker line) cell lines used
in this study. Cell line phenotypes are described (30-42).
Cell Line Human Origin Cell Line Establishment Tumor FormingPhenotype in Mice AR Expression
C4-2
Lymph node metastasis,
50-year-old Caucasian
male.
LNCaP subline isolated from C4 tumor
xenograft in castrated mouse. Tumors
from lymph node & bone.
Intrailiac or intrafemoral
injections; osteoblastic
lesions.
Yes
C4-2B
Lymph node metastasis,
50-year-old Caucasian
male.
LNCaP subline isolated from C4-2
tumor xenograft in castrated mouse.
Tumors isolated from bone.
Intrailiac or intrafemoral
injections; osteoblastic
lesions.
Yes
MDA PCa
2a & 2b
Bone metastasis, 63-year-
old African American
male.
2a & 2b are distinct clones from same
specimen. 2b cells generate tumors at a
higher rate than 2a cells in vivo.
Intrafemoral injection of
2b cells; osteoblastic
lesions.
Yes
VCaP
Vertebral bone metastasis,
59-year-old Caucasian
male.
Passaged as mouse xenograft then
cultured in vitro.
Intratibial injections;
osteoblastic lesions. Yes
DU145 Brain metastasis, 69-year-
old Caucasian male. Passaged in vitro
Injection into human
bone xenograft; osteolytic
lesions.
No
PC3 Bone metastasis, 62-year-
old Caucasian male.
Passaged as mouse xenograft then
cultured in vitro.
Injection into human
bone xenograft; osteolytic
lesions.
No
HS-5 Normal bone marrow, 30year-old Caucasian male.
Bone marrow cells immortalized using
LXSN-16 E6E7 retrovirus.
Small fibroblastic cells that secrete higher levels of
growth factors than HS27a cells & support
hematopoiesis in cell culture.
HS-27a Normal bone marrow, 30year-old Caucasian male.
Bone marrow cells immortalized using
LXSN-16 E6E7 retrovirus.
Large flattened epithelioid-like cells that support
cobblestone formation of hematopoietic cells in cell
culture.
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